Savolainen-Kopra Carita, Samoilovich Elena, Kahelin Heidi, Hiekka Anna-Kaisa, Hovi Tapani, Roivainen Merja
National Institute for Health and Welfare, Helsinki, Finland.
Immunoprofylaxis Laboratory, Research Institute of Epidemiology and Microbiology, Minsk, Belarus.
J Gen Virol. 2009 Aug;90(Pt 8):1859-1868. doi: 10.1099/vir.0.010942-0. Epub 2009 Apr 29.
The roles of recombination and accumulation of point mutations in the origin of new poliovirus (PV) characteristics have been hypothesized, but it is not known which are essential to evolution. We studied phenotypic differences between recombinant PV strains isolated from successive stool specimens of an oral PV vaccine recipient. The studied strains included three PV2/PV1 recombinants with increasing numbers of mutations in the VP1 gene, two of the three with an amino acid change I-->T in the DE-loop of VP1, their putative PV1 parent and strains Sabin 1 and 2. Growth of these viruses was examined in three cell lines: colorectal adenocarcinoma, neuroblastoma and HeLa. The main observation was a higher growth rate between 4 and 6 h post-infection of the two recombinants with the I-->T substitution. All recombinants grew at a higher rate than parental strains in the exponential phase of the replication cycle. In a temperature sensitivity test, the I-->T-substituted recombinants replicated equally well at an elevated temperature. Complete genome sequencing of the three recombinants revealed 12 (3), 19 (3) and 27 (3) nucleotide (amino acid) differences from Sabin. Mutations were located in regions defining attenuation, temperature sensitivity, antigenicity and the cis-acting replicating element. The recombination site was in the 5' end of 3D. In a competition assay, the most mutated recombinant beat parental Sabin in all three cell lines, strongly suggesting that this virus has an advantage. Two independent intertypic recombinants, PV3/PV1 and PV3/PV2, also showed similar growth advantages, but they also contained several point mutations. Thus, our data defend the hypothesis that accumulation of certain advantageous mutations plays a key role in gaining increased fitness.
关于重组和点突变积累在新脊髓灰质炎病毒(PV)特性起源中的作用已有假设,但尚不清楚哪些对于进化至关重要。我们研究了从口服PV疫苗接种者连续粪便标本中分离出的重组PV毒株之间的表型差异。所研究的毒株包括三个VP1基因中突变数量增加的PV2/PV1重组体,其中三个中的两个在VP1的DE环中有氨基酸变化I→T,它们假定的PV1亲本以及Sabin 1和2毒株。在三种细胞系中检测了这些病毒的生长情况:结肠直肠癌、神经母细胞瘤和HeLa细胞系。主要观察结果是在感染后4至6小时,具有I→T替换的两个重组体的生长速率更高。在复制周期的指数期,所有重组体的生长速率均高于亲本毒株。在温度敏感性试验中,I→T替换的重组体在升高的温度下复制情况同样良好。对这三个重组体的全基因组测序显示,与Sabin相比有12(3)、19(3)和27(3)个核苷酸(氨基酸)差异。突变位于定义减毒、温度敏感性、抗原性和顺式作用复制元件的区域。重组位点在3D的5'端。在竞争试验中,突变最多的重组体在所有三种细胞系中都击败了亲本Sabin,强烈表明这种病毒具有优势。两个独立的不同型重组体PV3/PV1和PV3/PV2也显示出类似的生长优势,但它们也包含几个点突变。因此,我们的数据支持了这样的假设,即某些有利突变的积累在获得更高适应性方面起着关键作用。